We pre-treated select ovarian cancer cells (OVCAR3 and KURAMOCHI) and organoids (EOC884 and EOC989) with gemcitabine for 18 h followed by combined WEE1 and PKMYT1 inhibition. Here, PKMYT1 is linked to ovarian cancer.